Provention Bio Inc. (PRVB) Prices 6.6M Share Common Offering at $14.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- Wall Street ends higher as US, Iran attacks ease; major tech-related shares jump
- Tech funds suffer record outflows as investors trim equity positions
- Comcast shares surge 23% on blockbuster plan to spin off NBCUniversal and Sky
- New leader board: Citi refreshes AI compute semiconductor picks
- Martin Marietta confirms $13.5B deal for Lhoist North America
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
- New leader board: Citi refreshes AI compute semiconductor picks
- Honeywell completes aerospace spin-off, splits into 3 companies
Pre-Open Movers 06/17: (WATT) (INWK) (GRPN) Higher; (CEMI) (ATNM) (NCLH) Lower (more...)
June 17, 2020 9:27 AM EDTToday's Pre-Open Stock Movers
Energous Corporation (Nasdaq: WATT) 66.5% HIGHER; announced a partnership with one of the worlds leading battery manufacturers in China, Grepow Battery. Energous and Grepow Battery are working together to develop batteries that are wirelessly charged via WattUp, a radio frequency (RF) based charging technology, for use in electronic devices in the commercial, industrial and medical industries.
Chembio Diagnostics (NASDAQ: CEMI) 60.4% LOWER; multiple downgrades
Aclaris Therapeutics, Inc. (NASDAQ:... More
After-Hours Movers 06/16: (INWK) (MGEN) (FLGT) Higher; (ATNM) (VOLT) (NCLH) Lower (more...)
June 16, 2020 5:20 PM EDTToday's After-Hours Stock Movers
InnerWorkings (NASDAQ: INWK) 39% HIGHER; reported Q1 EPS of $0.04, $0.04 better than the analyst estimate of $0.00. Revenue for the quarter came in at $261.4 million versus the consensus estimate of $267.98 million.
miRagen Therapeutics, Inc. (NASDAQ: MGEN) 37% HIGHER; scheduled to host a key opinion leaders (KOL) call regarding idiopathic pulmonary fibrosis (IPF) on Tuesday, June 23rd at 11 a.m. Eastern Time. The Company will also discuss encouraging new preclinical safety and efficacy data for its... More
Provention Bio Inc. (PRVB) Announces Proposed 5.5M Share Common Offering
June 16, 2020 4:02 PM EDTProvention Bio, Inc., (NASDAQ: PRVB) today announced that it has commenced an underwritten public offering of 5,500,000 shares of its common stock. All of the shares to be sold in the offering are to be sold by Provention Bio. In connection with the offering,... More
Provention Bio Inc. (PRVB) PT Raised to $26 at H.C. Wainwright
June 16, 2020 6:34 AM EDTH.C. Wainwright analyst Raghuram Selvaraju raised the price target on Provention Bio Inc. (NASDAQ: PRVB) to $26.00 (from $20.00) while maintaining a Buy rating.... More

